EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A host-directed oxadiazole compound potentiates antituberculosis treatment via zinc poisoning in human macrophages and in a mouse model of infection

Alexandra Maure, Emeline Lawarée, Francesco Fiorentino, Alexandre Pawlik, Saideep Gona, Alexandre Giraud-Gatineau, Matthew J G Eldridge, Anne Danckaert, David Hardy, Wafa Frigui, Camille Keck, Claude Gutierrez und 9 weitere

PLOS Biology · 2024

DOI: 10.1371/journal.pbio.3002259 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Biology, 2024. Verfasst von Alexandra Maure und 20 weiteren Autor:innen. Beteiligte Einrichtung: Institut Pasteur, Université Paris Cité, CNRS UMR 6047, Unit for Integrated Mycobacterial Pathogenomics, Paris, France. Hauptthemen laut MEDLINE: Oxadiazoles, Antitubercular Agents, Mycobacterium tuberculosis, Zinc. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institut Pasteur, French National Research Agency, Georges, Jacques and Elias Canetti Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antituberculosis drugs, mostly developed over 60 years ago, combined with a poorly effective vaccine, have failed to eradicate tuberculosis. More worryingly, multiresistant strains of Mycobacterium tuberculosis (MTB) are constantly emerging. Innovative strategies are thus urgently needed to improve tuberculosis treatment. Recently, host-directed therapy has emerged as a promising strategy to be used in adjunct with existing or future antibiotics, by improving innate immunity or limiting immunopathology. Here, using high-content imaging, we identified novel 1,2,4-oxadiazole-based compounds, which allow human macrophages to control MTB replication. Genome-wide gene expression analysis revealed that these molecules induced zinc remobilization inside cells, resulting in bacterial zinc intoxication. More importantly, we also demonstrated that, upon treatment with these novel compounds, MTB became even more sensitive to antituberculosis drugs, in vitro and in vivo, in a mouse model of tuberculosis. Manipulation of heavy metal homeostasis holds thus great promise to be exploited to develop host-directed therapeutic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxadiazolesAntitubercular AgentsMycobacterium tuberculosisZincMacrophagesDisease Models, AnimalTuberculosisAnimalsHumansMiceMice, Inbred C57BLFemaleDrug Synergism

Substanzen

OxadiazolesAntitubercular AgentsZinc

Autor:innen und Institutionen

  • Institut Pasteur, Université Paris Cité, CNRS UMR 6047, Unit for Integrated Mycobacterial Pathogenomics, Paris, France.
  • Department of Drug Chemistry and Technologies, Sapienza University of Rome, Rome, Italy.
  • Department of Genetic Medicine, University of Chicago, Chicago, Illinois, United States of America.
  • Institut Pasteur, Université Paris Cité, CNRS UMR 6047, Biology of Spirochetes Unit, Paris, France.
  • Institut Pasteur, Université Paris Cité, Chromatine et Infection unit, Paris, France.
  • Institut Pasteur, Université Paris Cité, UTechS BioImaging-C2RT, Paris, France.

ORCID-Profile: Ludovic Tailleux

Förderung

  • Institut Pasteur
  • French National Research Agency
  • Georges, Jacques and Elias Canetti Award
  • Agence Nationale de la Recherche
  • Région Île-de-France
  • Fondation pour la Recherche Médicale
  • Sapienza Università di Roma
  • Regione Lazio

Zitieren

APA

Maure, A., Lawarée, E., Fiorentino, F., Pawlik, A., Gona, S., Giraud-Gatineau, A., Eldridge, M. J. G., Danckaert, A., Hardy, D., Frigui, W., Keck, C., Gutierrez, C., Neyrolles, O., Aulner, N., Mai, A., Hamon, M., Barreiro, L. B., Brodin, P., Brosch, R., …, & Tailleux, L. (2024). A host-directed oxadiazole compound potentiates antituberculosis treatment via zinc poisoning in human macrophages and in a mouse model of infection. PLOS Biology. https://doi.org/10.1371/journal.pbio.3002259

Vancouver

Maure A, Lawarée E, Fiorentino F, Pawlik A, Gona S, Giraud-Gatineau A, et al. A host-directed oxadiazole compound potentiates antituberculosis treatment via zinc poisoning in human macrophages and in a mouse model of infection. PLOS Biology. 2024. doi:10.1371/journal.pbio.3002259

BibTeX
@article{Maure2024,
  author = {Maure, Alexandra and Lawarée, Emeline and Fiorentino, Francesco and Pawlik, Alexandre and Gona, Saideep and Giraud-Gatineau, Alexandre and Eldridge, Matthew J G and Danckaert, Anne and Hardy, David and Frigui, Wafa and Keck, Camille and Gutierrez, Claude and Neyrolles, Olivier and Aulner, Nathalie and Mai, Antonello and Hamon, Mélanie and Barreiro, Luis B and Brodin, Priscille and Brosch, Roland and Rotili, Dante and Tailleux, Ludovic},
  title = {A host-directed oxadiazole compound potentiates antituberculosis treatment via zinc poisoning in human macrophages and in a mouse model of infection},
  journal = {PLOS Biology},
  year = {2024},
  doi = {10.1371/journal.pbio.3002259}
}
Kostenlos starten →